Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
ID: 357710Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357710

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-247.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)." This initiative aims to develop a diverse, interdisciplinary workforce capable of conducting translational research on AD and ADRD, supporting training programs for predoctoral and postdoctoral researchers with varied educational backgrounds. The program emphasizes the importance of interdisciplinary collaboration and aims to enhance understanding and treatment of aging-related health issues. NIH plans to award an estimated 3-5 grants annually over the next three years, with a total budget of $2.7 million, and applications are due by September 25, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-247-Full-Announcement.html
    PAR-25-247.html
    The National Institutes of Health (NIH) is offering funding opportunities through a Notice of Funding Opportunity (NOFO) aimed at advancing translational research on Alzheimer's Disease (AD) and related dementias. The initiative, titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD-Related Dementias (T32 Clinical Trial Not Allowed)," is particularly focused on developing a diverse workforce of researchers capable of engaging in interdisciplinary team science. The program encourages proposals for training programs at both predoctoral and postdoctoral levels, emphasizing hands-on experience, collaboration across various scientific disciplines, and promoting diversity and inclusion. Key components of the grant include support for stipends, tuition, training-related expenses, and the requirement for applicants to submit via specific electronic submission systems. Applications are due by specified dates, with eligibility extended to diverse institutions, including minority-serving organizations. The overarching goal is to improve understanding and treatment of aging-related health issues while ensuring a commitment to scientific integrity and rigorous research training. The NIH intends to award an estimated 3-5 grants annually over the next three years, with a total budget of $2.7 million, contingent on appropriations and quality applications.
    Similar Opportunities
    Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)" aimed at developing a diverse and interdisciplinary workforce for translational research in this critical health area. The initiative invites eligible institutions to create training programs for predoctoral and postdoctoral researchers, focusing on enhancing skills in data science, disease biology, and drug discovery, while not permitting independent clinical trials. With an anticipated budget of approximately $2.7 million annually for 3-5 awards over fiscal years 2025-2027, applications are due by September 25, 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Institutional Translational Research Training Program (T32 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Institutional Translational Research Training Program (T32), a federal grant aimed at equipping advanced predoctoral students, postdoctoral fellows, and fellowship-stage clinicians with the skills necessary to advance basic research toward clinical application, particularly in the field of neuroscience. This program emphasizes a cohesive educational approach that integrates training in experimental design, statistical analysis, and effective communication, while fostering interdisciplinary collaboration among scientists and clinicians and providing exposure to industry and regulatory processes. The grant will cover stipends, tuition, and training-related expenses for a duration of two years, with a focus on enhancing diversity in biomedical research. Interested applicants can find more information and apply by May 25, 2026, and should direct inquiries to grantsinfo@nih.gov.
    NIA Predoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F31 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Predoctoral Fellowship Award aimed at promoting diversity in the translational research workforce focused on Alzheimer's disease and related dementias (AD/ADRD). This grant supports promising predoctoral candidates from diverse backgrounds in acquiring essential translational research skills, with an emphasis on interdisciplinary approaches to AD/ADRD research, although independent clinical trials are not permitted. The initiative is crucial for fostering a diverse pool of trained scientists capable of addressing the biomedical and social challenges associated with aging and dementia. The total funding available is $335,000 for six anticipated awards, with key application deadlines starting on March 8, 2025, and the final close date set for December 8, 2027. For more information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-333.html.
    NIA Postdoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Postdoctoral Fellowship Award (F32) to enhance diversity in the translational research workforce focused on Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD). This fellowship aims to support postdoctoral researchers from underrepresented backgrounds, emphasizing the development of translational research skills applicable to various aspects of AD/ADRD research, while prohibiting candidates from leading independent clinical trials. The program will fund approximately four awards totaling $420,000 in direct costs for fiscal years 2026-2028, with application cycles opening on March 8, 2025, and deadlines on April 8, August 8, and December 8 through 2027. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-332.html.
    NINDS Advanced Institutional Research Training Program (T32 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Advanced Institutional Research Training Program (T32), aimed at enhancing the training of well-qualified neuroscientists at the dissertation stage, postdoctoral fellows, and fellowship-stage clinicians. This program supports 1-2 years of mentorship and research development, focusing on diverse and rigorous training in neuroscience, including skills in scientific reasoning, experimental design, and statistical analysis, while prohibiting trainees from leading independent clinical trials. The initiative seeks to foster an inclusive research environment and bolster diverse representation within the research community, with awards covering stipends, tuition, travel, and essential training-related expenses. Applications are due by May 25 annually, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the official announcement link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-126.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for New Institutional Training Programs for Aging Research (T32, Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for new institutional training programs focused on aging research, specifically under the T32 grant mechanism, which does not allow clinical trials. The initiative aims to establish training programs that will cultivate a diverse pool of highly trained scientists to meet the nation's biomedical, behavioral, and clinical research needs in aging. This funding is critical as it supports predoctoral and postdoctoral research training, enhancing existing programs through tailored coursework and mentored research experiences. The estimated total program funding is $1,188,000, with three awards anticipated. The Notice of Funding Opportunity (NOFO) is expected to be published in February 2025, with applications due by May 2025, and awards projected to be made by March 2026.
    AD/ADRD Clinical Trials Short Course
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the AD/ADRD Clinical Trials Short Course aimed at enhancing the workforce skilled in Alzheimer's disease (AD) and AD-related dementias (ADRD) clinical trials. This initiative seeks to develop innovative short courses that will train the next generation of clinical trialists in advanced research skills pertinent to AD, frontotemporal dementia (FTD), Lewy body dementia (LBD), vascular contributions to cognitive impairment and dementia (VCID), and mixed dementia, as well as interventions for treatment and prevention. While applications are not currently being solicited, potential applicants are encouraged to begin forming collaborations and project ideas in anticipation of the funding opportunity, which will utilize the R25 activity code. For further inquiries, interested parties can contact Laurie Ryan at the National Institute on Aging via email at ryanl@mail.nih.gov or by phone at 301-496-9350. The estimated synopsis post date is September 1, 2025, with a closing date for applications expected by January 25, 2026, and an anticipated award date of December 1, 2026.
    Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)" aimed at advancing exploratory research in Alzheimer's disease (AD) and related dementias (ADRD). This initiative invites applications for innovative methodologies, animal models, and techniques that require preliminary data, with a focus on addressing health disparities among under-resourced populations. The program emphasizes the importance of interdisciplinary research to combat the public health crisis posed by AD and ADRD, with a maximum funding amount of $275,000 available over two years. Interested applicants must submit their proposals by November 16, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25), aimed at enhancing training for a skilled workforce in Alzheimer's Disease (AD) and Alzheimer's Disease and Related Dementias (ADRD). This program seeks to support educational activities that provide intensive research experiences for recent baccalaureates, particularly those from underrepresented backgrounds, to prepare them for advanced degree programs or research careers in AD/ADRD. The NIH plans to commit $2,000,000 in FY 2027 and FY 2028 to fund up to five new awards annually, with a maximum project period of five years and direct costs of up to $400,000 per year. Interested applicants can find more information and application details at the provided link and should direct inquiries to grantsinfo@nih.gov, with applications due by May 26, 2027.
    NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the NIA Expanding Research in Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) Summer Research Education Program (R25). This program aims to support the development and implementation of summer research education experiences for high school students, undergraduates, and science teachers, particularly those from underrepresented backgrounds, to enhance the research workforce in the AD/ADRD field. The initiative is crucial for providing early exposure to AD/ADRD research and encouraging participants to pursue careers in biomedical and behavioral sciences. Up to five awards of $200,000 in direct costs per year for up to five years are anticipated, with applications due by May 26, 2027. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.